Journal for ImmunoTherapy of Cancer (Nov 2023)
1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment
Abstract
No abstracts available.